- Nymox Pharmaceutical Corporation(NASDAQ: NYMX) tumbled 63.9% to close at $0.4555 on Monday after the company received a #Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
Subscribe to:
Post Comments (Atom)
ANGI
share 12.01 market 2.25 AVG 2.32 (2.95 ) % down today 0.88% purchase date 04 April 2024 2.34 3 April 2024 2.48 4 April 2024 2.30
-
ST ID stock number price TOTAL PRICE plan current price NUMBER OF SHARE current lost price net loss fill amount filled... -
Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) tumbled 63.9% to close at $0.4555 on Monday after the company received a #Refusal to Fil... -
Yeh Updating the market on its flagship immunotherapeutic agent pelareorep, Oncolytics Biotech Inc. (NASDAQ: ONCY ) (TSX:ONC) laid out its...
No comments:
Post a Comment